Cisen Pharmaceutical Co., Ltd. (SHA:603367)

China flag China · Delayed Price · Currency is CNY
17.21
+0.30 (1.77%)
Mar 10, 2026, 3:00 PM CST
28.91%
Market Cap 7.79B
Revenue (ttm) 3.56B
Net Income (ttm) 492.80M
Shares Out 452.75M
EPS (ttm) 1.08
PE Ratio 15.93
Forward PE n/a
Dividend 0.38 (2.22%)
Ex-Dividend Date Oct 13, 2025
Volume 5,581,474
Average Volume 6,400,781
Open 17.02
Previous Close 16.91
Day's Range 17.00 - 17.29
52-Week Range 12.86 - 35.20
Beta 0.32
RSI 42.49
Earnings Date Apr 3, 2026

About Cisen Pharmaceutical

Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, research, develops, produces, and sells drug products in China and internationally. The company’s chemical preparations include basic infusion, therapeutic infusion, liver disease medication, nervous system drugs, anti-tumor and adjuvant drugs, nutritional infusion, contrast agents, cardiovascular and cerebrovascular drugs, anti-infective drugs, narcotic analgesics, obstetrics and gynecology medication, digestive system medication, respiratory system medication, immune system drugs... [Read more]

Sector Healthcare
Founded 1970
Employees 3,302
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603367
Full Company Profile

Financial Performance

In 2024, Cisen Pharmaceutical's revenue was 3.98 billion, a decrease of -10.77% compared to the previous year's 4.46 billion. Earnings were 508.91 million, a decrease of -2.38%.

Financial Statements

News

There is no news available yet.